STOCK TITAN

Sage Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company focused on brain health, has announced it will host a live webcast on Wednesday, July 31, 2024, at 4:30 p.m. ET. The webcast will cover the company's second quarter 2024 financial results and provide updates on recent business activities. Investors and interested parties can access the webcast through the Investor page on Sage's website at investor.sagerx.com. A replay of the webcast will be available after the event and archived for up to 30 days.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that it will host a live webcast on Wednesday, July 31, 2024 at 4:30 p.m. ET to review second quarter 2024 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in Cambridge, Mass. Find out more at www.sagerx.com or engage with us on Facebook, LinkedIn, Instagram, and X.

Investor Contact

Ashley Kaplowitz

786-252-1419

ashley.kaplowitz@sagerx.com

Media Contact

Matthew Henson

917-930-7147

matthew.henson@sagerx.com

Source: Sage Therapeutics, Inc.

FAQ

When will Sage Therapeutics (SAGE) report its Q2 2024 financial results?

Sage Therapeutics (SAGE) will report its second quarter 2024 financial results on Wednesday, July 31, 2024, during a live webcast at 4:30 p.m. ET.

How can I access Sage Therapeutics' (SAGE) Q2 2024 earnings webcast?

You can access Sage Therapeutics' (SAGE) Q2 2024 earnings webcast on the Investor page of the company's website at investor.sagerx.com on July 31, 2024, at 4:30 p.m. ET.

Will there be a replay available for Sage Therapeutics' (SAGE) Q2 2024 earnings webcast?

Yes, a replay of Sage Therapeutics' (SAGE) Q2 2024 earnings webcast will be available following the completion of the event and will be archived for up to 30 days on the company's website.

What topics will be covered in Sage Therapeutics' (SAGE) Q2 2024 earnings call?

Sage Therapeutics' (SAGE) Q2 2024 earnings call will cover the company's second quarter 2024 financial results and provide updates on recent business activities.

Sage Therapeutics, Inc

NASDAQ:SAGE

SAGE Rankings

SAGE Latest News

SAGE Stock Data

452.27M
60.18M
11.9%
89.38%
9.71%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CAMBRIDGE